In Brief: OTC smoking cessation products
This article was originally published in The Tan Sheet
Executive Summary
OTC smoking cessation products: The Rx-to-OTC switches of SmithKline Beecham's Nicoderm CQ patch and Nicorette gum led to a 66% decline in the number of prescriptions for smoking cessation items to 69,000 in July, according to data from Scott-Levin. The Rx smoking cessation market was down 73% to $70 mil. during the year ended July 31, the firm notes...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning